ArticleJAMA oncology2024

Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma: The FUMANBA-1 Nonrandomized Clinical Trial.

Chunrui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.